Sat 24 Oct 2026 08:42:58 BST
Search Company
*

Active Substance
New Active Substance
Search Site
--
*

Create Site
--
*
*
*
*
*
*
Update Site
Current data stored in EudraGMDP databaseCurrent data stored in OMS
--
Characters remaining:4000/4000
New Active Substance Importation
Active Substance*
Active Substance (English):
Active Substance (NL):
NCA Reference Key:
3rd Country Manufacturer
3rd Country ManufacturerOMS Location IdentifierOMS Organisation IdentifierLegal AddressNCA Reference KeyConfidentialEditDelete
No records found.

3rd Country Distributor
3rd Country DistributorOMS Location IdentifierOMS Organisation IdentifierLegal AddressNCA Reference KeyConfidentialEditDelete
No records found.

Information Messages
  • The WDA has been withdrawn, withdrawn date is: 2026-01-26
  • RTF Template


    Regional Council Darmstadt

    UNION FORMAT FOR A WHOLESALE DISTRIBUTION AUTHORISATION


    1. Authorisation Number

    :

    DE_HE_01_WDA_2020_0037

    2. Name of Authorisation Holder

    :

    PHOENIX Pharma-Einkauf GmbH

    3. Address(es) of Site(s)

    :

    Donaustraße 11 a (Büro, Verwaltung), Hanau, Hessen, 63452, Germany 

    Lippestraße 9 a (Büro, Lager), Hanau, Hessen, 63452, Germany 




    4. Legally registered address of Authorisation Holder

    :

    Pfingstweidstraße 10-12, Mannheim, Hessen, 68199, Germany

    5. Scope of authorisation

    :

    ANNEX 1

    6. Legal basis of authorisation

    :


    7. Name of responsible officer of the competent authority of the member state granting the wholesale distribution authorisation

    :

    Confidential, Confidential

    8. Signature

    :


    9. Date

    :

    2020-09-04

    10. Annexes attached

    :

    Annex 1 Scope of wholesale distribution authorisation

    Annex 2 (Optional) Address(es) of contract wholesale distribution sites and their authorisation number

    Annex 3 (Optional) Name(s) of responsible person(s)

    Annex 4 (Optional) Date of Inspection on which authorisation was granted

    Annex 5 (Optional) Additional provisions based on national requirements


    ANNEX 1

    SCOPE OF WHOLESALE DISTRIBUTION AUTHORISATION



    Name and address of the site: PHOENIX Pharma-Einkauf GmbH

    , Donaustraße 11 a (Büro, Verwaltung), Hanau, Hessen, 63452, Germany   




    1. MEDICINAL PRODUCTS

       1.1. with a Marketing Authorisation in EEA country(s)

       1.2. without a Marketing Authorisation in the EEA and intended for EEA market


    2. AUTHORISED WHOLESALE DISTRIBUTION OPERATIONS

       2.1. Procurement 

       2.3. Supply 

       2.4. Export 

       2.5. Other activities(s): holding and supply as an outsourced activity in an external warehouse (see Annex 2), drop shipmentLagerung und Lieferung (Abgabe) in einem beauftragten Betrieb (siehe Anlage 2), Streckengeschäfte


    3. MEDICINAL PRODUCTS WITH ADDITIONAL REQUIREMENTS

         3.1.1. Narcotic or psychotropic products 

         3.1.2. Medicinal products derived from blood 

         3.1.3. Immunological medicinal products 

       3.3. Cold chain products(requiring low temperature handling) 




    Any restrictions or clarifying remarks (for all users):  Import acc. to Sec. 73 subsec. 3 German Drug Law.

    Durchführung des Verbringens gem. § 73 Abs. 3 AMG.


    Name and address of the site: PHOENIX Pharma- Einkauf GmbH

    , Lippestraße 9 a (Büro, Lager), Hanau, Hessen, 63452, Germany   




    1. MEDICINAL PRODUCTS

       1.1. with a Marketing Authorisation in EEA country(s)

       1.2. without a Marketing Authorisation in the EEA and intended for EEA market


    2. AUTHORISED WHOLESALE DISTRIBUTION OPERATIONS

       2.1. Procurement 

       2.2. Holding 

       2.3. Supply 

       2.4. Export 

       2.5. Other activities(s): holding and supply as an outsourced activity in an external warehouse (see Annex 2), drop shipmentLagerung und Lieferung (Abgabe) in einem beauftragten Betrieb (siehe Anlage 2), Streckengeschäfte


    3. MEDICINAL PRODUCTS WITH ADDITIONAL REQUIREMENTS

         3.1.1. Narcotic or psychotropic products 

         3.1.2. Medicinal products derived from blood 

         3.1.3. Immunological medicinal products 

       3.3. Cold chain products(requiring low temperature handling) 




    Any restrictions or clarifying remarks (for all users):  Import acc. to Sec. 73 subsec. 3 German Drug Law.

    Durchführung des Verbringens gem. § 73 Abs. 3 AMG.








    Reason for Withdrawing:

    A new WDA was issued von 26.01.2026.

    Es wurde eine aktualisierte GHE am 26.01.2026 erteilt.








    Union Format for a Wholesale Distribution Authorisation

    DE_HE_01_WDA_2020_0037


    Page 1





    Loading, please wait